PlainRecalls
FDA Drug Moderate Class II Completed

Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015 USA. Manufactured by: Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India. NDC 36000-012-25

Reported: December 13, 2023 Initiated: November 14, 2023 #D-0146-2024

Product Description

Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015 USA. Manufactured by: Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India. NDC 36000-012-25

Reason for Recall

Failed pH Specifications

Details

Units Affected
6,022,675 vials
Distribution
Nationwide in the USA
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015 USA. Manufactured by: Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India. NDC 36000-012-25. Recalled by Baxter Healthcare Corporation. Units affected: 6,022,675 vials.
Why was this product recalled?
Failed pH Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on December 13, 2023. Severity: Moderate. Recall number: D-0146-2024.